Up First from NPR - DOJ Targets Minnesota Officials; Hash Ukraine Winter; AI Harmful In Child Education
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy

my private podcast channel
We hear from a woman whose determination to avoid going blind has inspired her doctors to develop a new treatment for a rare eye condition. Nicki Guy says the injection of a low cost, water-based gel has been life changing and given her the chance to see her son grow up. The treatment has already helped restore the eyesight of dozens of other people with hypotony - which can cause the eye to collapse, leading to blindness.
Also: the new Barbie doll that's designed to help improve understanding and acceptance of autism. A neurodiverse writer says she hopes it will help young girls understand it's not something to hide or be ashamed of. A revolutionary way of treating some cancers is being offered to people in the UK with an aggressive form of leukaemia for the first time. Research has shown genetically modifying the patient's own cells to recognise the blood cancer, can extend their lives or, in some cases, offer a cure. Plus, how one man's regular habit of having gumbo at the same restaurant twice a day may have saved his life; the 24-year-old in charge of protecting the Pacific Ocean around the remote Pitcairn island; and the amateur football team who pulled off one of the biggest upsets in English footballing history by beating a side from the Premier League.
Our weekly collection of inspiring, uplifting and happy news from around the world.
Presenter: Valerie Sanderson. Music composed by Iona Hampson Picture: PA
Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The ultrarunner and mountaineer finds peace through doing unimaginably hard things.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
President Trump REALLY wants to invoke the Insurrection Act. He’s fallen hard for this 200-year-old law that would allow him to deploy active duty military to enforce civilian law on American streets. On this week’s Amicus podcast, co-host Mark Joseph Stern is joined by Professor Steve Vladeck, a nationally recognized expert on the Supreme Court, federal courts, national security law, and military justice. They discuss what’s been stopping Trump from invoking the act so far, why he has no legal authority to do so right now, and what happens if he does it anyway.
Next, Mark talks to Julia Gegenheimer, former special litigation counsel in the Justice Department’s Civil Rights Division’s Criminal Section, and now a special litigation counsel at Georgetown Law’s Institute for Constitutional Advocacy and Protection. Julia and Mark discuss the remaining paths to justice after the killing of Renee Good and examine what happens when the DOJ abandons its duty to seek accountability and vindicate civil rights.
Want more Amicus? Join Slate Plus to unlock weekly bonus episodes with exclusive legal analysis. Plus, you’ll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Amicus show page on Apple Podcasts and Spotify. Or, visit slate.com/amicusplus to get access wherever you listen.
Hosted on Acast. See acast.com/privacy for more information.
In Autumn 2025 a paper in South Korea was published that excited many a vaccine sceptic online. The paper claimed that receiving a vaccination against Covid19 was linked to a 27% increase in cancer risk.
However, when you dig into the data there is no evidence that the vaccine caused the cancer. We spoke to Professor Justin Fendos to explain why we cannot take this type of statistical analysis at face value.
Presenter: Tim Harford Producer: Lizzy McNeill Series Producer: Tom Colls Editor: Richard Vadon Production Coordinator: Brenda Brown Sound Mix: James Beard